Any current/future new fundraising through debt or equity?

For FY2027, the standalone business capex is expected to be around Rs. 300 to 350 Crores. Additional investments of around Rs. 300 Crores are estimated for subsidiaries, including the EV business (TICMPL) and TI Medical. No explicit mention of new fundraising through debt or equity was made during the call. The company is focused on internal funding for capex and expansion. Acquisition mentioned (Medicura facility) was an asset purchase done at an attractive price and is already closed, with no indication of new fundraising tied to it. Overall, the management did not indicate any immediate pla

Any current/future capex/capital investment/strategic investment?

Capex guidance for FY2027 standalone business is around Rs. 300 Crores to Rs. 350 Crores. Additional investment of approximately Rs. 300 Crores is expected for subsidiaries, including TI Clean Mobility Private Limited (TICMPL) and TI Medical. Recent strategic acquisition: Purchase of Medicura facility at Ambala for IV cannula business; plant approval is in progress and commercial production expected in Q1/Q2 FY2027. CDMO business plant at Naidupet is in final commissioning with commercial production slated to start next quarter. Future expansion plans are under consideration, like further ramp

Future growth expectations in sales/revenue/volumes?

Engineering business volume growth is in line with sales growth; Q4 FY2026 volume growth matched revenue growth. Volume growth remains strong entering Q1 FY2027 despite macro challenges; commodity price inflation is partially passed through; fuel cost pressures are being addressed. EV business sees strong order book and increasing demand, especially in heavy and small commercial vehicles; deployment challenges (financing and charging infrastructure) are being worked on, with expected scaling in Q1 and Q2 FY2027. Medical devices (TI Medical) expects 15-20% year-on-year growth; recent acqu

Future growth expectations in earnings/operating earnings/profits/EPS?

TI Medical business is expected to grow at 15-20% year-on-year, driven by new product development and recent acquisition (Medicura asset purchase). The engineering business shows volume growth in line with revenue growth; management remains bullish on volume growth despite macro challenges. Metal formed products (MFP) segment is currently sluggish but expected to recover after overcoming some customer-specific issues. Electric Vehicle (EV) business sees strong order books for heavy trucks and small commercial vehicles with ongoing cost reduction and localization efforts aimed at scaling up. Ch

Current/ Expected Orderbook/ Pending Orders?

Tube Investments of India is currently sitting on a very good order book for their electric vehicles, especially in the heavy truck segment and small commercial vehicle segment (Page 6-7). They expect to deploy these trucks in Q1 and Q2 of FY2027, indicating a healthy pipeline of pending orders (Page 6). For the three-wheeler business, after resolving supply issues, there is confidence in a good scale-up of volumes, reflecting strong demand/orders (Page 7). The company is working on orders related to their swap battery technology, particularly for applications like ports (Page 7). No specific

IN US

Sale is live|00:00:00left today

Tube Investments of India LtdQ1 FY26Auto Components

Tube Investments of India Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,258P/E: 92.3Market Cap: ₹57.1K CrSector: Auto Components

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Engineering business volume growth is in line with sales growth; Q4 FY2026 volume growth matched revenue growth.
→Volume growth remains strong entering Q1 FY2027 despite macro challenges; commodity price inflation is partially passed through; fuel cost pressures are being addressed.
→EV business sees strong order book and increasing demand, especially in heavy and small commercial vehicles; deployment challenges (financing and charging infrastructure) are being worked on, with expected scaling in Q1 and Q2 FY2027.
→Medical devices (TI Medical) expects 15-20% year-on-year growth; recent acquisition (Medicura asset purchase) to add growth from Q1/Q2 FY2027 as commercial production begins.
→Railway business scale-up is ongoing with product approvals in progress; progress expected over 2-3 quarters.
→Overall, bullish on volume and revenue growth with strategic investments and cost reduction initiatives to support scaling.

Margin guidance

Category 3

→TI Medical business is expected to grow at 15-20% year-on-year, driven by new product development and recent acquisition (Medicura asset purchase).
→The engineering business shows volume growth in line with revenue growth; management remains bullish on volume growth despite macro challenges.
→Metal formed products (MFP) segment is currently sluggish but expected to recover after overcoming some customer-specific issues.
→Electric Vehicle (EV) business sees strong order books for heavy trucks and small commercial vehicles with ongoing cost reduction and localization efforts aimed at scaling up.
→Challenges remain in EV deployment related to financing and charging infrastructure; however, management is optimistic about resolving these and scaling volumes in Q1 and Q2 FY2027.
→Capex guidance: Rs. 300-350 Crores for core business for FY2027; approx. Rs. 300 Crores for subsidiaries including EV and medical businesses.
→Overall, free cash flow was 100% of PAT, showcasing efficient cash generation supporting growth investments.

3 more insights locked — sign up free to unlock

Fundraise plans

→For FY2027, the standalone business capex is expected to be around Rs. 300 to 350 Crores.
→Additional investments of around Rs. 300 Crores are estimated for subsidiaries, including the EV business (TICMPL) and TI Medical.
→No explicit mention of new fundraising through debt or equity was made during the call.
→The company is focused on internal funding for capex and expansion.
→Acquisition mentioned (Medicura facility) was an asset purchase done at an attractive price and is already closed, with no indication of new fundraising tied to it.
→Overall, the management did not indicate any immediate plans for raising fresh debt or equity in the discussed period.

Order book

Yes

→Tube Investments of India is currently sitting on a very good order book for their electric vehicles, especially in the heavy truck segment and small commercial vehicle segment (Page 6-7).
→They expect to deploy these trucks in Q1 and Q2 of FY2027, indicating a healthy pipeline of pending orders (Page 6).
→For the three-wheeler business, after resolving supply issues, there is confidence in a good scale-up of volumes, reflecting strong demand/orders (Page 7).
→The company is working on orders related to their swap battery technology, particularly for applications like ports (Page 7).
→No specific numeric order book figures shared, but demand is strong with ongoing scaling initiatives across EV and other segments.

Capex plans

Yes

→Capex guidance for FY2027 standalone business is around Rs. 300 Crores to Rs. 350 Crores.
→Additional investment of approximately Rs. 300 Crores is expected for subsidiaries, including TI Clean Mobility Private Limited (TICMPL) and TI Medical.
→Recent strategic acquisition: Purchase of Medicura facility at Ambala for IV cannula business; plant approval is in progress and commercial production expected in Q1/Q2 FY2027.
→CDMO business plant at Naidupet is in final commissioning with commercial production slated to start next quarter.
→Future expansion plans are under consideration, like further ramp-up at CRSS plant in Nasik and steel tube facilities in Western India once current capacities reach full utilization.

How does Tube Investments of India Ltd rank vs peers in Auto Components?

Pro feature

1Tube Investments of India Ltd

Rev 3Mar 3

See full Auto Components sector rankings

Want more stocks like Tube Investments of India Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio